Solasia Pharma KK
F:9SO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Solasia Pharma KK
F:9SO
|
JP |
|
Wijaya Karya (Persero) Tbk PT
F:5AA
|
ID |
|
A
|
Assured Guaranty Ltd
F:DHU
|
BM |
|
C
|
China Evergrande Group
XMUN:EV1
|
CN |
|
Great Elm Group Inc
F:PNC
|
US |
|
P
|
Pro DV AG
DUS:PDA
|
DE |
|
E
|
ELL Environmental Holdings Ltd
F:6EL
|
CN |
|
Eiger BioPharmaceuticals Inc
OTC:EIGRQ
|
US |
|
C
|
Central China Securities Co Ltd
SWB:21C
|
CN |
|
T
|
Toyoda Gosei Co Ltd
F:11T
|
JP |
|
Galena Mining Ltd
F:GM6
|
AU |
|
F
|
FNB Corp
F:FN2
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9SO's stock price target?
Not Available
9SO does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Solasia Pharma KK?
Projected CAGR
158%
Over the last 10 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 2 years is 158%.
What is the Gross Profit forecast for Solasia Pharma KK?
Projected CAGR
39%
Over the last 10 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 3 years is 39%.